Show simple item record

dc.contributor.authorYildiz, Yemliha
dc.contributor.authorYaylim, Ilhan
dc.contributor.authorOzkan, Nazli E.
dc.contributor.authorArikan, Soykan
dc.contributor.authorTuran, Saime
dc.contributor.authorKucucuk, Seden
dc.contributor.authorCoskunpinar, Ender
dc.contributor.authorIsbir, Turgay
dc.date.accessioned2016-10-25T06:54:57Z
dc.date.available2016-10-25T06:54:57Z
dc.date.issued2013-01
dc.identifier.citationAmerican Journal of Molecular Biology, 2013, 3, 10-16en_US
dc.identifier.urihttp://dx.doi.org/10.4236/ajmb.2013.31002
dc.identifier.urihttp://hdl.handle.net/123456789/1028
dc.description.abstractBax is an important protein involved in apoptotic process. Mutations of the Bax gene are known to af- fect protein expression and function. A promotor polymorphism G(-248)A in the 5’UTR of Bax gene may alter regulation of apoptosis in carcinogenesis. Our study was performed to test the association be- tween G(-248)A polymorphisms in the Bax gene and breast cancer risk and progression. G(-248)A poly- morphism was genotyped in a Turkish breast cancer, case-control population including 53 female cancer patients (mean age ± SD: 60.9 ± 11.9 years) and 82 controls (mean age ± SD: 57.2 ± 17.5 years) using PCR-RFLP analysis. Genotype and allele frequencies were assessed with the chi-square test. There was no difference in the distribution of Bax genotypes, and allele frequencies were G (87.7% versus 88.4%) and A (12.3% versus 11.6%) in the cancer patients and controls, respectively. Within the cancer group, the presence of a polymorphic Bax G(-248)A allele was not associated with clinico-pathological parameters such as advanced tumor stage, lymph node or distant metastasis. We present the first to report on Bax G(-248)A polymorphisms in breast cancer. Our re- sults suggest that Bax G(-248)A polymorphism do not modify individual susceptibility to invasive breast cancer in Turkish women.en_US
dc.language.isoenen_US
dc.publisherScientific Research Publishingen_US
dc.subjectBcl-2 Associated-X-Proteinen_US
dc.subjectSNPen_US
dc.subjectApoptosisen_US
dc.subjectPCRen_US
dc.subjectSusceptibilityen_US
dc.subjectCarcinogenesisen_US
dc.titleBax promoter G(-248)A polymorphism in a Turkish clinical breast cancer patients: A case-control studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record